Canine Atopic Dermatitis

Canine Atopic Dermatitis Market Outlook

The global Canine Atopic Dermatitis market is anticipated to reach a valuation of approximately $XX billion by 2035, growing at a significant compound annual growth rate (CAGR) of XX% from 2025 to 2035. The increasing prevalence of skin disorders among dogs and the rising expenditure on pet healthcare are primary factors driving this market growth. In addition, heightened awareness among pet owners about the importance of dermatological care for their furry companions has spurred demand for specialized treatment options. Innovations in veterinary pharmaceuticals and the development of advanced therapies tailored for canine atopic dermatitis are also propelling market expansion. Furthermore, the trend of pet humanization, where pet owners increasingly treat their pets as family members, is leading to increased spending on high-quality and effective dermatological products.

Growth Factor of the Market

The growth factors driving the Canine Atopic Dermatitis market include the significant rise in the population of pet dogs globally and the concurrent increase in the incidence of atopic dermatitis among canines. Growing awareness regarding pet health and wellness is prompting pet owners to seek effective treatments for skin conditions, thereby boosting market demand. Additionally, advancements in veterinary medicine, including the introduction of new therapeutic options and products, are contributing to market growth. The increasing disposable income of pet owners allows for greater spending on premium pet care products, including specialized treatments for skin ailments. Moreover, the expansion of e-commerce platforms dedicated to pet health products is enhancing accessibility and convenience for consumers, further stimulating market growth.

Key Highlights of the Market

• The market is projected to grow significantly due to the rising incidence of canine skin disorders.
• Increased investments in research and development for innovative therapeutic solutions are expected to drive growth.
• Growing awareness about pet health among owners is leading to higher demand for specialized dermatological products.
• The rise of e-commerce channels and online veterinary consultations is enhancing product accessibility.
• The trend of pet humanization continues to influence purchasing decisions, pushing market growth.

By Product Type

Topical Treatments:

Topical treatments are among the most commonly utilized options in managing canine atopic dermatitis. These treatments include creams, ointments, and gels that are applied directly to the affected areas on the dog's skin. The primary advantage of topical treatments is their localized action, which helps to alleviate itching and inflammation effectively while minimizing systemic side effects. Many pet owners prefer topical solutions due to their ease of application and immediate relief they provide to their pets. With ongoing research, formulations are becoming more sophisticated, incorporating active ingredients that enhance their efficacy in treating skin conditions. As awareness of the benefits of these treatments grows, this segment is expected to witness significant growth in the market.

Oral Medications:

Oral medications for canine atopic dermatitis represent a crucial segment of the market, providing a systemic approach to treatment. These medications include antihistamines, corticosteroids, and newer immunomodulating agents that work to reduce the inflammatory response in dogs. The convenience of oral administration is a key factor driving the adoption of this treatment type, especially for dogs that may resist topical applications. Moreover, the development of flavored tablets and soft chews has made oral medications more palatable for pets, further enhancing compliance among pet owners. As the demand for effective and easy-to-administer solutions increases, the oral medications segment is expected to see substantial growth in the coming years.

Immunotherapy:

Immunotherapy is gaining traction in the management of canine atopic dermatitis, reflecting a shift toward personalized veterinary care. This treatment method involves administering allergen-specific immunotherapy, which helps to desensitize the dog's immune system to specific allergens causing the dermatitis. Immunotherapy can be delivered via injections or sublingual tablets, offering a targeted approach that can lead to long-term relief from symptoms. Although this treatment may take time to show results, its potential to address the root cause of the condition rather than merely alleviating symptoms makes it an appealing option for many pet owners. The rising awareness of immunotherapy's benefits is expected to contribute to its growth in the canine dermatology market.

Medicated Shampoos:

Medicated shampoos are an essential part of the treatment regimen for canine atopic dermatitis, providing both cleansing and therapeutic benefits. These shampoos contain active ingredients that target inflammation, reduce itching, and promote skin health. Regular use of medicated shampoos can help control flare-ups and maintain the skin's barrier function, making them a popular choice among veterinarians and pet owners alike. The formulation of these shampoos has evolved to include soothing agents and natural extracts that enhance their effectiveness and make them more appealing to use. As a growing number of pet owners recognize the importance of regular skin care for their dogs, the demand for medicated shampoos is anticipated to rise significantly.

Dietary Supplements:

Dietary supplements play a pivotal role in the management of canine atopic dermatitis by supporting overall skin health from the inside out. Supplements typically include fatty acids, omega-3 and omega-6, antioxidants, and other nutrients that can help improve skin condition and reduce inflammation. The increasing focus on holistic pet care has led to a surge in the popularity of dietary supplements, as pet owners seek natural alternatives to pharmaceuticals. Companies are increasingly developing specialized formulations that cater to the specific needs of dogs suffering from skin conditions. As the trend toward preventive health care continues to grow, the dietary supplements segment is expected to experience substantial growth in the market.

By Application

Veterinary Clinics:

Veterinary clinics are a major application segment for canine atopic dermatitis treatments, as they are the primary points of care for pet health issues. Pet owners often seek professional veterinary advice when they notice symptoms of skin disorders, leading to a high demand for dermatological products in these settings. Veterinary clinics typically provide comprehensive diagnostic services and treatment plans tailored to individual dogs, helping to ensure effective management of atopic dermatitis. Furthermore, the relationship between veterinarians and pet owners fosters trust, encouraging owners to follow through with recommended treatments. As veterinary care continues to evolve, the reliance on specialized treatments available in clinics is expected to drive significant growth in this segment.

Retail Pharmacies:

Retail pharmacies play a significant role in providing canine atopic dermatitis treatments, serving as accessible points for pet owners to obtain over-the-counter medications and supplements. Many pet owners prefer the convenience of retail pharmacies, where they can quickly find products without needing to visit a veterinary clinic for minor skin issues. The availability of a wide range of dermatological products in retail pharmacies enhances consumer choices, allowing pet owners to select treatments based on their specific needs and preferences. Additionally, retail pharmacies often run promotional campaigns and hold educational sessions that raise awareness about pet dermatology, further stimulating demand within this channel.

E-commerce:

The e-commerce segment is rapidly transforming the landscape of the canine atopic dermatitis market by providing pet owners with a modern and convenient way to purchase treatments and products. Online platforms enable consumers to access a vast array of dermatological options from the comfort of their homes, often at competitive prices. The rise of direct-to-consumer brands and subscription services has also allowed pet owners to receive their preferred products regularly, ensuring consistent care for their pets. Furthermore, the proliferation of online resources and forums has empowered pet owners with knowledge about atopic dermatitis, leading to informed purchasing decisions. As e-commerce continues to evolve, this segment is expected to experience robust growth as it meets the needs and preferences of modern consumers.

By Distribution Channel

Online Stores:

Online stores are a significant distribution channel for canine atopic dermatitis products, offering convenience and accessibility to pet owners in need of effective treatments. As more consumers turn to online shopping for their pet care needs, the variety of products readily available on these platforms has expanded. Online stores often feature detailed product descriptions, user reviews, and comparisons, which help consumers make informed decisions. Additionally, many online retailers provide subscription services, allowing for regular deliveries of essential products, thereby ensuring that pet owners never run out of their dog's medications or treatments. With the ongoing trend of digital shopping, this distribution channel is poised for substantial growth.

Veterinary Hospitals:

Veterinary hospitals serve as a crucial distribution channel for canine atopic dermatitis treatments, providing a professional setting where specialized care is delivered. These institutions typically have access to a broader range of prescription medications and advanced therapeutic options that may not be available through retail outlets. The expertise of veterinary professionals ensures that pet owners receive tailored treatment plans, which often include a combination of medications and ongoing monitoring of the dog's condition. As veterinary hospitals continue to promote comprehensive pet care and dermatological solutions, their role in the distribution of canine atopic dermatitis products remains pivotal.

Pet Specialty Stores:

Pet specialty stores are increasingly becoming important distribution channels for canine atopic dermatitis treatments, as they offer a curated selection of products that cater specifically to pet health. These stores typically stock high-quality, specialized brands that are often recommended by veterinarians, ensuring that pet owners have access to effective solutions. The knowledgeable staff at these stores can provide valuable insights and recommendations, helping pet owners choose the right products for their dogs. As consumers continue to seek out premium pet care options, the influence of pet specialty stores in the market for canine atopic dermatitis is likely to grow.

Drug Stores:

Drug stores are a vital distribution channel for canine atopic dermatitis treatments, as they provide easy access to a range of over-the-counter solutions for pet owners. In many cases, these stores carry popular brands of medicated shampoos, topical treatments, and dietary supplements that can be used to manage skin conditions in dogs. The convenience of purchasing pet health products at local drug stores appeals to many consumers, as they can combine pet care shopping with their regular errands. Additionally, many drug stores offer loyalty programs and promotions on pet care products, which can incentivize pet owners to make purchases in this channel. As the trend toward convenience continues, drug stores will likely maintain their role as an important distribution point for canine atopic dermatitis treatments.

By Ingredient Type

Corticosteroids:

Corticosteroids are a cornerstone ingredient in the treatment of canine atopic dermatitis, primarily due to their potent anti-inflammatory properties. These medications can be administered orally, topically, or via injection, providing flexibility in treatment approaches depending on the severity of the condition. Corticosteroids work by inhibiting the immune response that contributes to skin inflammation, effectively reducing itching and discomfort in affected dogs. As veterinarians often prescribe these medications for immediate symptom relief, the demand for corticosteroid-based products remains robust. However, the potential for side effects with prolonged use has prompted the development of alternative therapies, influencing market dynamics.

Antihistamines:

Antihistamines are commonly used as a first-line treatment for managing pruritus associated with canine atopic dermatitis. These medications work by blocking the action of histamine, a chemical released during allergic reactions that contributes to itching and discomfort. Available in oral and topical forms, antihistamines are often favored for their relatively low side-effect profile and ease of administration. Many pet owners turn to antihistamines as a non-steroidal option, especially for mild cases of dermatitis. The growing awareness of allergy management in dogs is expected to bolster the demand for antihistamine-based treatments in the market.

Immunomodulators:

Immunomodulators represent a newer class of ingredients in the treatment of canine atopic dermatitis, designed to regulate the immune response rather than suppress it. These medications can help address the underlying causes of allergies while minimizing the risk of significant side effects associated with corticosteroids. Immunomodulators such as cyclosporine have gained popularity for their effectiveness and long-term safety profile. As more veterinarians adopt these advanced therapies and educate pet owners about their benefits, the immunomodulator segment is likely to expand, reflecting a shift toward more thoughtful and sustainable approaches to managing canine dermatological conditions.

Fatty Acids:

Fatty acids, particularly omega-3 and omega-6, are increasingly recognized for their role in promoting skin health and alleviating the symptoms of canine atopic dermatitis. These essential fatty acids contribute to maintaining the integrity of the skin barrier, reducing inflammation, and improving overall coat condition. Many pet owners are turning to dietary supplements rich in fatty acids to support their dogs' skin health holistically. The growing trend of pet owners seeking natural and preventive solutions is driving the demand for fatty acid-based products in the market. As research continues to uncover the benefits of fatty acids in dermatological care, this segment is poised for continued growth.

Herbal Extracts:

Herbal extracts are gaining traction in the canine atopic dermatitis market as pet owners increasingly seek natural alternatives to traditional pharmaceuticals. These extracts can provide anti-inflammatory, soothing, and healing properties, making them valuable adjuncts in the management of skin conditions. Formulations that incorporate herbal ingredients often resonate with the holistic approach many owners are adopting for their pets' health. The rise of natural pet care products has opened opportunities for the development of innovative treatments that blend traditional knowledge with modern veterinary practices. As awareness and demand for herbal solutions continue to grow, this segment is expected to play an increasingly significant role in the canine dermatology market.

By Region

The North American region holds the largest share of the Canine Atopic Dermatitis market, accounting for approximately XX% of the total market revenue. The factors contributing to this dominance include a high pet ownership rate, increased awareness of pet health, and advanced veterinary care facilities. Additionally, the prevalence of allergies and skin conditions among dogs in this region is relatively high, which drives demand for effective treatment options. The North American market is expected to witness a CAGR of XX% from 2025 to 2035, fueled by continuous innovations in the development of new therapeutic products and the expansion of e-commerce platforms dedicated to pet health.

In Europe, the Canine Atopic Dermatitis market is also experiencing robust growth, driven by a growing population of pet dogs and an increasing focus on pet wellness. The European market is projected to account for around XX% of the global share, with countries like Germany, the UK, and France leading in terms of market size. The rise of veterinary practices and the availability of specialized dermatological products in retail and online channels support this growth. European consumers are increasingly seeking premium pet care products, which contributes to the overall market expansion in the region. The market in Europe is anticipated to witness a steady growth rate of XX% during the forecast period.

Opportunities

The Canine Atopic Dermatitis market presents numerous opportunities for growth, particularly through advancements in veterinary medicine and increased consumer awareness. Innovations in treatment formulations, such as long-acting injectable therapies and customized immunotherapy, are paving the way for more effective management of atopic dermatitis. As research continues to unveil the complexities of canine allergies, the development of targeted therapies may provide new avenues for addressing the underlying causes of skin conditions. Additionally, the rising trend of pet humanization is driving pet owners to seek more premium and effective solutions for their pets' health, creating a lucrative opportunity for companies to develop high-quality products that cater to this growing demand.

Moreover, the burgeoning e-commerce sector offers significant opportunities for market players to expand their reach and increase sales. The convenience of online shopping has transformed consumer behavior, allowing pet owners to access an array of dermatological products with just a few clicks. By investing in digital marketing and enhancing their online presence, companies can tap into this trend and educate consumers about the importance of treating canine atopic dermatitis effectively. Collaborations with e-commerce platforms and influencers can further amplify brand visibility and drive sales, creating a win-win situation for both consumers and companies in the market.

Threats

Despite the promising outlook for the Canine Atopic Dermatitis market, several threats could hinder growth in the coming years. One of the primary concerns is the potential for regulatory challenges associated with veterinary pharmaceuticals. As the market evolves and new products are developed, companies may face stringent regulatory scrutiny, resulting in delays in product launches or increased costs for compliance. Additionally, the presence of counterfeit products and substandard treatments in the market poses a significant threat to both consumer safety and brand reputation. As awareness of pet dermatology increases, pet owners may become more discerning about product quality, making it imperative for companies to ensure the safety and efficacy of their offerings.

Another threat to the market is the rising trend of self-medication among pet owners. With the increasing availability of over-the-counter treatments, some pet owners may opt for cheaper or less effective options without consulting a veterinarian. This trend could lead to inadequate management of atopic dermatitis, resulting in exacerbated symptoms and potential long-term health issues for pets. The challenge for market players will be to educate consumers on the importance of professional veterinary care and the benefits of using prescribed products over unregulated alternatives. Balancing consumer access with safety and efficacy will be crucial in addressing this threat.

Competitor Outlook

• Zoetis Inc.
• Elanco Animal Health
• Merck Animal Health
• Vetoquinol S.A.
• Boehringer Ingelheim
• Ceva Santé Animale
• PetIQ, Inc.
• Hill's Pet Nutrition, Inc.
• Royal Canin
• Nestlé Purina PetCare
• Vet’s Best
• Virbac Corporation
• PetSafe Brand
• Nutramax Laboratories
• Zesty Paws

The competitive landscape of the Canine Atopic Dermatitis market is characterized by a diverse array of companies ranging from large multinational corporations to specialized start-ups. Major players such as Zoetis Inc., Elanco Animal Health, and Merck Animal Health dominate the market due to their extensive product portfolios that include various treatment options for canine dermatological conditions. These companies invest significantly in research and development, allowing them to innovate and introduce new therapies that address the evolving needs of pet owners. Additionally, established brands benefit from strong distribution networks and relationships with veterinary professionals, ensuring their products remain accessible to consumers and veterinarians alike.

In contrast, smaller companies and start-ups are also making strides in the market by focusing on niche products and natural alternatives. Firms such as Vet’s Best and Zesty Paws cater to the growing demand for holistic and natural healthcare solutions, appealing to pet owners who prefer non-pharmaceutical approaches to managing atopic dermatitis. This shift toward natural treatments is reshaping the competitive landscape, as more consumers recognize the importance of holistic pet care. Moreover, the rise of e-commerce platforms has enabled these smaller players to reach a wider audience, leveling the playing field against larger corporations.

Key players in the market, such as Boehringer Ingelheim and Virbac Corporation, are expanding their product offerings and focusing on strategic partnerships with veterinary clinics and online retailers to enhance market penetration. Collaborations with research institutions and veterinary colleges also play a crucial role in driving innovation and improving treatment options available for canine atopic dermatitis. As competition intensifies, companies are expected to leverage marketing strategies that emphasize product efficacy and safety to differentiate their offerings in a crowded marketplace.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Zesty Paws
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 PetIQ, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Royal Canin
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Zoetis Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 PetSafe Brand
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Vetoquinol S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Virbac Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Merck Animal Health
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Boehringer Ingelheim
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Elanco Animal Health
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Nutramax Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Vet’s Best
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ceva Santé Animale
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hill's Pet Nutrition, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Nestlé Purina PetCare
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Canine Atopic Dermatitis Market, By Application
    • 6.1.1 Veterinary Clinics
    • 6.1.2 Retail Pharmacies
    • 6.1.3 E-commerce
  • 6.2 Canine Atopic Dermatitis Market, By Product Type
    • 6.2.1 Topical Treatments
    • 6.2.2 Oral Medications
    • 6.2.3 Immunotherapy
    • 6.2.4 Medicated Shampoos
    • 6.2.5 Dietary Supplements
  • 6.3 Canine Atopic Dermatitis Market, By Ingredient Type
    • 6.3.1 Corticosteroids
    • 6.3.2 Antihistamines
    • 6.3.3 Immunomodulators
    • 6.3.4 Fatty Acids
    • 6.3.5 Herbal Extracts
  • 6.4 Canine Atopic Dermatitis Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Veterinary Hospitals
    • 6.4.3 Pet Specialty Stores
    • 6.4.4 Drug Stores
    • 6.4.5 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Canine Atopic Dermatitis Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Canine Atopic Dermatitis market is categorized based on

By Product Type

• Topical Treatments
• Oral Medications
• Immunotherapy
• Medicated Shampoos
• Dietary Supplements

By Application

• Veterinary Clinics
• Retail Pharmacies
• E-commerce

By Distribution Channel

• Online Stores
• Veterinary Hospitals
• Pet Specialty Stores
• Drug Stores
• Retail Pharmacies

By Ingredient Type

• Corticosteroids
• Antihistamines
• Immunomodulators
• Fatty Acids
• Herbal Extracts

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Zoetis Inc.
• Elanco Animal Health
• Merck Animal Health
• Vetoquinol S.A.
• Boehringer Ingelheim
• Ceva Santé Animale
• PetIQ, Inc.
• Hill's Pet Nutrition, Inc.
• Royal Canin
• Nestlé Purina PetCare
• Vet’s Best
• Virbac Corporation
• PetSafe Brand
• Nutramax Laboratories
• Zesty Paws